Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.

Saved in:
Bibliographic Details
Title: Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspective.
Authors: Eratne D; Neuropsychiatry Centre, The Royal Melbourne Hospital, Melbourne, VIC, Australia.; National Dementia Diagnostics Laboratory, The Florey Institute, The University of Melbourne, Melbourne, VIC, Australia.; Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia., Collins S; National Dementia Diagnostics Laboratory, The Florey Institute, The University of Melbourne, Melbourne, VIC, Australia.; Department of Medicine The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia., Nestor PJ; Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.; Mater Public Hospital, South Brisbane, QLD, Australia., Pond D; Wicking Dementia Research and Teaching Centre, University of Tasmania, Hobart, TAS, Australia., Velakoulis D; Neuropsychiatry Centre, The Royal Melbourne Hospital, Melbourne, VIC, Australia., Yates M; Grampians Health, Ballarat, VIC, Australia.; Deakin University, Burwood, VIC, Australia., Masters CL; National Dementia Diagnostics Laboratory, The Florey Institute, The University of Melbourne, Melbourne, VIC, Australia.
Source: Frontiers in psychiatry [Front Psychiatry] 2024 Dec 05; Vol. 15, pp. 1488494. Date of Electronic Publication: 2024 Dec 05 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-0640
DOI:10.3389/fpsyt.2024.1488494